by TractManager | Apr 29, 2022 | Emerging Technology Report
The BlueLeaf Endovenous Valve Formation (EVF) System is an endovascular device intended to form autogenous tissue leaflets from femoral and popliteal vein walls that mimic a functional valve. It is under investigation for the treatment of deep vein reflux in chronic...
by TractManager | Apr 29, 2022 | Emerging Technology Report
Mavacamten (Camzyos) is an oral cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.If you have a Hayes...
by TractManager | Apr 26, 2022 | Publications
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the PillCam patency capsule (Medtronic) for verifying small bowel patency in adult patients with known or...
by TractManager | Apr 26, 2022 | Molecular Test Assessment
This report evaluates the clinical utility of the FoundationOne CDx test for the intended use as a broad molecular profiling tool.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 26, 2022 | Emerging Technology Report
Narsoplimab is an investigational, intravenous monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).If you have a Hayes login,...
Recent Comments